FlowLac 90
D-Glucose, 4-O-ß-D-galactopyranosyl-, hydrate (1:1)Item #: 3253
Best available price
Benefits FlowLac 90
- Excellent flowability and outstanding compactibility
- Virtually dust free
- Compliance with Ph. Our., USP-NF and JP monographs
- High speed compression
- Fast disintegration times
- Smooth surface - glossy tablets
Packaging Description
- Carton boxes of 25 KG. One full pallet is 40 boxes (1,000 KG)
Leadtime
Available for shipment within 1 weekProduct information FlowLac 90
Description
Meggle's product FlowLac® is produced by spray-drying a suspension of fine milled alpha-lactose monohydrate crystals in a solution of lactose. When lactose in solution is spray-dried, a rapid removal of water is taking place, whereby amorphous, non-crystalline lactose is formed in addition to crystalline lactose. Based on the amorphous content, kept on a stable level, non-varying better tabletting properties can be reached.
Due to the spray-drying process, FlowLac® has a spherical agglomerate shape, consisting of small alpha-lactose monohydrate crystals bound by amorphous lactose. FlowLac® 90 was developed to provide greater compactability compared to FlowLac® 100 by optimizing the amorphous lactose content. In addition, the particle size distribution makes FlowLac® 90 virtually dust-free.
Areas of application:
Due to the spray-drying process, FlowLac® has a spherical agglomerate shape, consisting of small alpha-lactose monohydrate crystals bound by amorphous lactose. FlowLac® 90 was developed to provide greater compactability compared to FlowLac® 100 by optimizing the amorphous lactose content. In addition, the particle size distribution makes FlowLac® 90 virtually dust-free.
Areas of application:
- Low to medium dose DC formulations
- Formulations with poorly flowing API's
- Capsule and sachet filling
Chemical Name
D-Glucose, 4-O-ß-D-galactopyranosyl-, hydrate (1:1)
HS Code
1702.11
CAS Number
64044-51-5
Product Form
Solid
Region of Origin
European Union
Markets, applications & functions FlowLac 90
Product Functions
N/A
Similar or equivalent to
.
Applications
Nutra dosage forms, Oral dosage
SubMarket
Nutraceutical, Pharmaceutical
Market
Pharmaceutical
Product Hazard information
CLP-GHS pictograms
Transport Hazard Indication
Non Dangerous GoodsTransport Hazard Class
Not ApplicableProduct documents
ACB Cationic Glycoprotein PF
Lactobacillus/Eriodictyon Californicum Ferment Extract; Phospholipids; Leuconostoc/Radish Root Ferment Filtrate
Item #: 2241
